Search Orphan Drug Designations and Approvals
-
| Generic Name: | Trans-Cinnamic Acid |
|---|---|
| Date Designated: | 02/03/2021 |
| Orphan Designation: | Treatment of Krabbe disease |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Polaryx Therapeutics, Inc. 140 E. Ridgewood Avenue, Suite 415, South Tower Paramus , New Jersey 07652 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
